Grail
Menlo Park, CA · Founded 2015 · CIK 0001699031 · Medtech · Public
Blood test technology for early cancer detection
grail.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $1.7B
- 4 Form D · Nov 2025
- 11 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 15 granted · 25 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $914,024,940 | |
| Private capital raised | Form D · SEC | $300,000,000 | |
| Private capital raised | Form D · SEC | $125,000,000 | |
| Private capital raised | Form D · SEC | $324,997,989 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1290 | 3DP Security Inc | — | — |
| 1291 | CATHPRO TECHNOLOGIES LLC | — | — |
| 1292 | CROSSLINER INC | — | — |
| 1293 | Grail | — | $1.7B |
| 1294 | PARATECHS CORP | — | — |
| 1295 | SCALAR MAGNETICS, LLC | — | — |
| 1296 | Vital Connect, Inc. | — | $83M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- HAL BARRONDirector
- Jose BaselgaDirector
- HANS BISHOPDirector · Executive Officer
- Brook ByersDirector
- William ChaseDirector
- Jennifer CookDirector · Executive Officer
- Min CuiDirector
- MIN CUIDirector
- Kaye FosterDirector
- KAYE FOSTERDirector
- Kaye Foster-CheekDirector
- Aaron FreidinExecutive Officer
- Catherine FriedmanDirector
- CATHERINE FRIEDMANDirector
- MAYKIN HODirector
- Jeffrey HuberDirector · Executive Officer
- JEFFREY HUBERDirector
- Richard KlausnerDirector
- RICHARD KLAUSNERDirector
- Sarah KrevansDirector
- Steve MizellDirector
- Robert NelsenDirector
- ROBERT NELSENDirector
- Josh OfmanExecutive Officer
- Robert RagusaDirector · Executive Officer
- William RastetterDirector · Executive Officer
- WILLIAM RASTETTERDirector
- Gregory SummeDirector
Patents
- Systems And Methods For Cancer Condition Determination Using Autoencodersapplication
- Systems And Methods For Diagnosing A Condition Using On-target And Off-target Sequencing Dataapplication
- Systems And Methods For Autonomous Workflow Managementapplication
- Systems And Methods For End-to-end Material Managementapplication
- Systems And Methods For Transporting A Sample In A Laboratoryapplication
- Methods Using Characteristics Of Urinary And Other Dnaapplication
- Methods And Systems For Tumor Detectiongranted
- Method And System Of Cancer Detection Using Cpg-snp Contamination Markersgranted
- Systems And Methods For Identifying Clonal Expansion Of Abnormal Lymphocytesapplication
- Methylation Markers And Targeted Methylation Probe Panelsapplication
- Methods For Analyzing Viral Nucleic Acidapplication
- Systems And Methods For Cancer Condition Determination Using Autoencodersgranted
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.